Nano-Cap Bio-Path Takes Plunge In Weight Loss Race, Initiates Obesity Program With Drug Candidate Under Development For Blood Cancer

Benzinga21:27

TD Cowen Maintains AbbVie(ABBV.US) With Buy Rating, Raises Target Price to $225

Futu News12:32 · Ratings

In-Depth Examination Of 11 Analyst Recommendations For AbbVie

Benzinga03:00

AbbVie Is Maintained at Buy by TD Cowen

Dow Jones01:49 · Ratings

AbbVie Analyst Ratings

Benzinga01:37 · Ratings

AbbVie Insiders Sell US$56m Of Stock, Possibly Signalling Caution

Simply Wall StOct 7 22:49